Simulations Plus SLP Development — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Simulations Plus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Simulations Plus's development — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Simulations Plus's development — revenue?
- Simulations Plus (SLP) reported development — revenue of $18.86M in Q4 2025.
- What does development — revenue mean?
- This metric represents the total gross revenue generated from the development segment, which encompasses specialized software solutions and associated consulting services for pharmaceutical research. It serves as a primary indicator of the company's ability to monetize its intellectual property and technical expertise within the drug discovery and development lifecycle. Tracking this revenue stream helps investors assess the scale and growth trajectory of the core business offerings.